CN110693036A - Ultrasound-assisted dialysis-driven zein self-assembly to prepare nanoparticles - Google Patents
Ultrasound-assisted dialysis-driven zein self-assembly to prepare nanoparticles Download PDFInfo
- Publication number
- CN110693036A CN110693036A CN201910879019.0A CN201910879019A CN110693036A CN 110693036 A CN110693036 A CN 110693036A CN 201910879019 A CN201910879019 A CN 201910879019A CN 110693036 A CN110693036 A CN 110693036A
- Authority
- CN
- China
- Prior art keywords
- zein
- ultrasonic
- dialysis
- nanoparticles
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002494 Zein Polymers 0.000 title claims abstract description 138
- 239000005019 zein Substances 0.000 title claims abstract description 138
- 229940093612 zein Drugs 0.000 title claims abstract description 138
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 121
- 238000000502 dialysis Methods 0.000 title claims abstract description 75
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 18
- 238000001338 self-assembly Methods 0.000 title claims abstract description 11
- 239000002245 particle Substances 0.000 claims abstract description 119
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 29
- 102000011632 Caseins Human genes 0.000 claims description 42
- 108010076119 Caseins Proteins 0.000 claims description 42
- 229940080237 sodium caseinate Drugs 0.000 claims description 42
- 239000011259 mixed solution Substances 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000008367 deionised water Substances 0.000 claims description 21
- 229910021641 deionized water Inorganic materials 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- 239000002131 composite material Substances 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 238000001246 colloidal dispersion Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011550 stock solution Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 abstract description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 15
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 238000009210 therapy by ultrasound Methods 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 235000013376 functional food Nutrition 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract description 3
- 230000000996 additive effect Effects 0.000 abstract description 3
- 235000021474 generally recognized As safe (food) Nutrition 0.000 abstract description 3
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 238000004880 explosion Methods 0.000 abstract description 2
- 238000005259 measurement Methods 0.000 description 24
- 238000009826 distribution Methods 0.000 description 16
- 230000005284 excitation Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 238000002189 fluorescence spectrum Methods 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 8
- 238000002296 dynamic light scattering Methods 0.000 description 8
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 8
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 8
- 239000002114 nanocomposite Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 5
- 238000000527 sonication Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 239000012296 anti-solvent Substances 0.000 description 4
- 229920001222 biopolymer Polymers 0.000 description 3
- 230000002051 biphasic effect Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/32—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using phonon wave energy, e.g. sound or ultrasonic waves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了超声辅助透析驱动玉米醇溶蛋白自组装制备纳米颗粒方法,属于功能性食品技术领域。本发明使用组合频率超声辅助透析来制备纳米颗粒,前期使用超声辅助透析,后期只使用透析。本发明特点在于:一是使用了无酒精食品中的添加剂丙二醇(GRAS),避免使用酒精,降低了易燃易爆的风险,减少了生产成本。二是在去除溶剂时利用双相物理驱动力(超声与浓度差)促进形成均匀、尺寸较小的纳米颗粒。三是避免使用酸碱溶液,反应过程易于实现自动化生产。最终不同组合频率超声对形成经过超声处理后的纳米颗粒粒径明显减小,并且提高了纳米粒子的储藏稳定性,为生物活性化合物的递送系统提供新方法。
The invention discloses a method for preparing nano-particles by ultrasonic-assisted dialysis-driven zein self-assembly, and belongs to the technical field of functional food. The invention uses combined frequency ultrasonic-assisted dialysis to prepare nanoparticles, and uses ultrasonic-assisted dialysis in the early stage, and only uses dialysis in the later stage. The present invention has the following characteristics: firstly, the additive propylene glycol (GRAS) in alcohol-free food is used, which avoids the use of alcohol, reduces the risk of inflammability and explosion, and reduces the production cost. The second is to use a two-phase physical driving force (ultrasonic and concentration difference) to promote the formation of uniform and smaller-sized nanoparticles during solvent removal. The third is to avoid the use of acid-base solutions, and the reaction process is easy to achieve automated production. Finally, different combined frequencies of ultrasound can significantly reduce the particle size of the nanoparticles after ultrasonic treatment, and improve the storage stability of the nanoparticles, providing a new method for the delivery system of biologically active compounds.
Description
技术领域technical field
本发明属于功能性食品技术领域,具体涉及利用超声辅助透析来驱动玉米醇溶蛋白自组装形成纳米颗粒的新方法。The invention belongs to the technical field of functional foods, and in particular relates to a new method for driving zein self-assembly to form nanoparticles by using ultrasonic-assisted dialysis.
背景技术Background technique
来源于有机生物聚合物并且粒径达到纳米级别的颗粒称为纳米粒子,纳米粒子粒径小、亲水性高、有较高的环境适应性,并且在胃肠消化中的吸收利用率较高,提高了被包封活性物质的生物利用度,因此纳米粒子被广泛应用在负载亲脂疏水营养素的递送系统中。Particles derived from organic biopolymers and with a particle size reaching the nanometer level are called nanoparticles. Nanoparticles have small particle size, high hydrophilicity, high environmental adaptability, and high absorption and utilization in gastrointestinal digestion. , which improves the bioavailability of the encapsulated active substances, so nanoparticles are widely used in delivery systems loaded with lipophilic and hydrophobic nutrients.
玉米醇溶蛋白是玉米胚乳中的主要储存蛋白,是玉米在食品工业生产中的主要副产品。它由不同分子量与溶解度的多肽组成,根据溶解度和氨基酸序列不同可分为四种:α-玉米醇溶蛋白(19和22KD)、β-玉米醇溶蛋白(14KD)、δ-玉米醇溶蛋白(16和27KD)、γ-玉米醇溶蛋白(10KD)。α-玉米醇溶蛋白占比最高,γ-玉米醇溶蛋白次之。玉米醇溶蛋白具有独特的天然理化特性,水溶性差,但能够溶解在高浓度的醇溶液中。利用玉米醇溶蛋白独特溶解性可制备食品级纳米颗粒,并且玉米醇溶蛋白被公认是安全的食品成分(GRAS)。玉米醇溶蛋白亲脂性氨基酸残基占比较高(≥50%)属高疏水性蛋白,因此具有递送非极性生物活性化合物的潜力。Zein is the main storage protein in maize endosperm and the main by-product of maize in the food industry. It is composed of polypeptides with different molecular weights and solubility, and can be divided into four types according to the solubility and amino acid sequence: α-zein (19 and 22KD), β-zein (14KD), δ-zein (16 and 27KD), gamma-zein (10KD). Alpha-zein accounted for the highest proportion, followed by gamma-zein. Zein has unique natural physicochemical properties, poor water solubility, but can be dissolved in high concentration alcohol solution. Food-grade nanoparticles can be prepared using the unique solubility of zein, and zein is recognized as a safe food ingredient (GRAS). Zein with a high proportion of lipophilic amino acid residues (≥50%) is a highly hydrophobic protein and therefore has the potential to deliver non-polar bioactive compounds.
玉米醇溶蛋白纳米粒子对加工环境具有高度敏感性,因此需要添加生物聚合物在其疏水性表面形成保护壳,避免纳米颗粒发生聚集沉淀。此外,添加的生物聚合物对形成的纳米颗粒的核壳结构还具有良好的储存稳定性、被包封物质的抗降解的稳定性和高包封效率。酪蛋白酸钠作为一种小分子表面活性剂,具有两亲性基团,可降低玉米醇溶蛋白的表面疏水性,增加静电引力和空间稳定性,防止玉米醇溶蛋白聚集,可用在反溶剂法、pH循环驱动、超声辅助透析等方法形成的食品级纳米颗粒递送系统中。Zein nanoparticles are highly sensitive to the processing environment, so biopolymers need to be added to form a protective shell on their hydrophobic surface to avoid aggregation and precipitation of nanoparticles. In addition, the added biopolymer also has good storage stability, anti-degradation stability of the encapsulated substance, and high encapsulation efficiency to the core-shell structure of the formed nanoparticles. As a small molecule surfactant, sodium caseinate has an amphiphilic group, which can reduce the surface hydrophobicity of zein, increase electrostatic attraction and steric stability, prevent the aggregation of zein, and can be used as an anti-solvent In the food-grade nanoparticle delivery system formed by methods such as method, pH cycle driving, ultrasonic-assisted dialysis, etc.
超声辅助透析驱动玉米醇溶蛋白纳米颗粒自组装的原理是利用玉米醇溶蛋白在不同极性溶剂中的溶解度不同。玉米醇溶蛋白首先溶解在溶剂中,在超声辅助作用下,玉米醇溶蛋白溶液分散,溶剂在浓度差与超声的驱动力下,与强极性溶剂水进行传质,从而不断降低溶剂的浓度,玉米醇溶蛋白逐渐形成纳米微球,并且在超声机械效应、空化作用下,形成均一稳定、粒径较小的玉米醇溶蛋白纳米颗粒。The principle of ultrasound-assisted dialysis-driven self-assembly of zein nanoparticles is to exploit the different solubility of zein in different polar solvents. Zein is first dissolved in the solvent, and under the assistance of ultrasound, the zein solution is dispersed, and the solvent is mass-transferred with the strong polar solvent water under the driving force of the concentration difference and ultrasound, thereby continuously reducing the concentration of the solvent , zein gradually formed nano-microspheres, and under the action of ultrasonic mechanical effect and cavitation, zein nanoparticles with uniform and stable size and smaller particle size were formed.
制备玉米醇溶蛋白自组装纳米颗粒的方法有反溶剂法、pH循环驱动法等。反溶剂法中通常使用乙醇,乙醇不能应用于无酒精食品,并且易燃,对于工业生产过程十分不利,粒径大小取决于滴加反溶剂的体积,并且去除溶剂旋蒸操作过程较为繁琐,增加生产成本,不利于自动化生产过程。pH循环驱动法避免了使用乙醇,但是需要精确调控pH,使用大量的酸碱溶液,并且调节过程属于动态变化过程,影响因素较多。The methods for preparing zein self-assembled nanoparticles include anti-solvent method, pH cycle driving method, etc. Ethanol is usually used in the anti-solvent method. Ethanol cannot be used in alcohol-free food and is flammable. It is very unfavorable for industrial production processes. The particle size depends on the volume of anti-solvent added dropwise. Production costs are not conducive to automated production processes. The pH cycle driving method avoids the use of ethanol, but requires precise adjustment of pH, the use of a large amount of acid-base solution, and the adjustment process is a dynamic change process with many influencing factors.
为了解决这些问题,本发明使用组合频率超声辅助透析来制备纳米颗粒,一是使用了无酒精食品中的添加剂丙二醇(GRAS),避免使用酒精,降低了易燃易爆的风险,减少了生产成本。二是在去除溶剂时利用双相物理驱动力(超声与浓度差)促进形成均匀、尺寸较小的纳米颗粒。三是避免使用酸碱溶液,反应过程易于实现自动化生产。最终不同组合频率超声对形成经过超声处理后的纳米颗粒粒径明显减小,并且提高了纳米粒子的储藏稳定性,为生物活性化合物的递送系统提供新方法,并且提高了对于环境耐受力较弱的营养素的生物利用度,扩大了亲脂性生物活性化合物在功能性食品的应用范围。In order to solve these problems, the present invention uses combined frequency ultrasonic-assisted dialysis to prepare nanoparticles. First, the additive propylene glycol (GRAS) in alcohol-free food is used, which avoids the use of alcohol, reduces the risk of inflammability and explosion, and reduces production costs. . The second is to use a two-phase physical driving force (ultrasonic and concentration difference) to promote the formation of uniform and smaller-sized nanoparticles during solvent removal. The third is to avoid the use of acid-base solutions, and the reaction process is easy to achieve automated production. Finally, different combined frequencies of ultrasonics significantly reduce the particle size of the nanoparticles after ultrasonic treatment, and improve the storage stability of nanoparticles, provide a new method for the delivery system of biologically active compounds, and improve the environmental tolerance. The weak bioavailability of nutrients expands the application scope of lipophilic bioactive compounds in functional foods.
发明内容SUMMARY OF THE INVENTION
本发明的目的是使用双相物理驱动力(超声与浓度差)形成均匀稳定、粒径较小的玉米醇溶蛋白纳米颗粒,前期使用超声辅助透析,后期只使用透析。并且避免使用乙醇,使用食品级添加剂丙二醇作为溶剂,开拓驱动玉米醇溶蛋白纳米颗粒自组装的新方法。The purpose of the present invention is to use biphasic physical driving force (ultrasonic and concentration difference) to form zein nanoparticles with uniform, stable and smaller particle size. Ultrasonic-assisted dialysis is used in the early stage, and only dialysis is used in the later stage. And avoiding the use of ethanol, using the food-grade additive propylene glycol as a solvent, opens up new ways to drive the self-assembly of zein nanoparticles.
本发明的技术方案如下:The technical scheme of the present invention is as follows:
超声辅助透析驱动玉米醇溶蛋白自组装制备纳米颗粒的方法,按照下述步骤进行:The method for preparing nanoparticles by ultrasonic-assisted dialysis-driven zein self-assembly is carried out according to the following steps:
(1)称取一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在丙二醇水溶液中,储备溶液磁力搅拌均匀目视无明显沉淀,离心去除不溶性的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Weigh a certain mass of zein and sodium caseinate and dissolve them in an aqueous propylene glycol solution, stir the stock solution evenly with a magnetic force and see no obvious precipitation, and remove insoluble large particles by centrifugation to obtain zein and caseinic acid. A binary mixed solution of sodium.
(2)将玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入一定长度的透析袋中,将透析袋密封好放入物料容器中,并加入去离子水;玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液与去离子水的比例是1:20;(2) Put the binary mixed solution of zein and sodium caseinate into a dialysis bag of a certain length, seal the dialysis bag and put it into the material container, and add deionized water; The ratio of the binary mixed solution of sodium caseinate to deionized water is 1:20;
(3)把物料容器放置在超声槽中,设置超声频率、超声功率、超声时间、超声方式以及恒温水浴,超声60min,取出透析袋,重新加入与步骤(2)体积相等的去离子水在室温条件下进行透析。(3) Put the material container in the ultrasonic tank, set the ultrasonic frequency, ultrasonic power, ultrasonic time, ultrasonic mode and constant temperature water bath, ultrasonic for 60min, take out the dialysis bag, re-add deionized water equal to the volume of step (2) at room temperature dialysis under conditions.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
其中步骤(1)中的玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,丙二醇水溶液的浓度为80%(v/v),二元混合溶液经5000rpm离心10min去除残留的大颗粒混合溶液的制备在室温下进行。Wherein the mass ratio of zein and sodium caseinate in step (1) is 2%, the concentration of propylene glycol aqueous solution is 80% (v/v), the binary mixed solution is centrifuged at 5000rpm for 10min to remove residual large The preparation of the particle mixed solution is carried out at room temperature.
其中步骤(2)中的透析袋的规格为34mm(宽度),截留分子量为8000-14000,使用的透析袋经过活化并且使用的长度为45cm。Wherein the specification of the dialysis bag in step (2) is 34mm (width), the molecular weight cut off is 8000-14000, the used dialysis bag is activated and the used length is 45cm.
其中步骤(3)中超声频率为组合频率超声,分别为20KHz、28KHz、40KHz、20KHz+28KHz、28KHz+40KHz、20KHz+40KHz、20KHz+28KHz+40KHz,超声功率为300W,超声方式为连续式超声,恒温水浴的温度为25℃。The ultrasonic frequency in step (3) is the combined frequency ultrasonic, respectively 20KHz, 28KHz, 40KHz, 20KHz+28KHz, 28KHz+40KHz, 20KHz+40KHz, 20KHz+28KHz+40KHz, the ultrasonic power is 300W, and the ultrasonic mode is continuous ultrasonic , the temperature of the constant temperature water bath is 25 ℃.
与现有技术相比,本发明的优点和技术效果是:Compared with the prior art, the advantages and technical effects of the present invention are:
1.本发明使用了双相物理驱动力,有助于玉米醇溶蛋白纳米颗粒的形成。在透析过程中加入了超声辅助处理,超声能够打开玉米醇溶蛋白内部的结构使其变得疏松,暴露出内部的发色基团,反应更加充分,从而与酪蛋白酸钠结合形成更为紧密的结构从而减小复合纳米颗粒的尺寸。并且在透析过程中加入的超声有助于提高传质速率,促进复合纳米颗粒的形成。1. The present invention uses a biphasic physical driving force to facilitate the formation of zein nanoparticles. Ultrasonic assisted treatment is added during the dialysis process. Ultrasound can open the internal structure of zein to make it loose, expose the internal chromophore, and react more fully, thereby combining with sodium caseinate to form a tighter form. structure to reduce the size of composite nanoparticles. And the added ultrasound during dialysis helps to increase the mass transfer rate and promote the formation of composite nanoparticles.
2.本发明中避免使用乙醇,从而减少去除乙醇的成本以及有利于无酒精食品的开发,更降低了易燃易爆的风险,并且操作过程中不使用有机试剂,整个过程简单容易操作,有利于包埋生物活性化合物的递送系统的连续化生产。2. The use of ethanol is avoided in the present invention, thereby reducing the cost of removing ethanol and facilitating the development of alcohol-free food, further reducing the risk of inflammable and explosive, and without using organic reagents in the operation process, the whole process is simple and easy to operate, and has Facilitates the continuous production of delivery systems for embedding biologically active compounds.
3.本发明利用超声辅助透析的新方法形成的玉米醇溶蛋白复合纳米颗粒,不仅颗粒的粒径小、均一稳定,并且可以提高复合纳米粒子的储藏稳定性。3. The zein composite nanoparticles formed by the new method of ultrasonic-assisted dialysis in the present invention not only have small particle size, uniform and stable particle size, but also can improve the storage stability of the composite nanoparticles.
4.本发明提高了玉米淀粉副产物的利用率,为生物活性化合物的递送系统提供新方法,并且提高了对于环境耐受力较弱的营养素的生物利用度,扩大了亲脂性生物活性化合物在功能性食品的应用范围。4. The present invention improves the utilization rate of corn starch by-products, provides a new method for the delivery system of bioactive compounds, and improves the bioavailability of nutrients with weaker environmental tolerance, and expands the lipophilic bioactive compounds in the bioactive compounds. The scope of application of functional food.
附图说明Description of drawings
图1是超声辅助透析驱动玉米醇溶蛋白自组装制备纳米颗粒工艺流程图;Fig. 1 is the process flow diagram of ultrasonic-assisted dialysis-driven zein self-assembly to prepare nanoparticles;
图2是不同组合频率超声辅助透析的纳米颗粒的荧光光谱图。Figure 2 is the fluorescence spectra of nanoparticles for different combined frequencies of ultrasound-assisted dialysis.
具体实施方式Detailed ways
下面结合具体实例以及数据,来进一步对本发明技术方案进行详细的描述。但这些实例并不对本发明的技术方案有限制作用,只是举例说明。The technical solutions of the present invention are further described in detail below in conjunction with specific examples and data. However, these examples are not intended to limit the technical solutions of the present invention, but are merely illustrative.
实施例1Example 1
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在室温条件下进行透析12h(3) Place the material container at room temperature for 12h dialysis
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。不进行超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为256.62±6.78nm,PDI为0.13±0.07,电位为-30.78±0.42mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径272.45±9.65nm,PDI为0.18±0.07电位为-20.46±2.93mv。在储藏过程中,未经超声处理的二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI增大但是不显著,电位则是往减小的方向转移。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm. The particle size of fresh zein nanoparticles without sonication was 256.62 ± 6.78 nm, the PDI was 0.13 ± 0.07, the potential was -30.78 ± 0.42 mv, and the particle size of zein nanoparticles stored for 15 days 272.45±9.65nm, PDI is 0.18±0.07 potential is -20.46±2.93mv. During the storage process, the particle size of the unsonicated binary zein nanoparticles showed an increasing trend, the PDI increased but not significantly, and the potential shifted to a decreasing direction.
实施例2Example 2
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为20KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 20KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, the temperature of the constant temperature water bath to be 25°C, take out the dialysis bag, and re-add 400mL of deionized Water was dialyzed at room temperature for 11 h.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。进行20KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为239.90±8.57nm,PDI为0.11±0.04,电位为-37.78±0.38mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径254.75±12.10nm,PDI为0.16±0.06,电位为-31.44±2.31mv。与实施例1相比较,粒径明显减小,PDI减小,粒径分布较窄,粒度分布均匀,并且电位增加,说明超声促进了均一稳定二元玉米醇溶蛋白纳米颗粒的形成。在储藏过程中,二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI增大但是不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm. The particle size of fresh zein nanoparticles subjected to 20KHz sonication was 239.90 ± 8.57 nm, the PDI was 0.11 ± 0.04, the potential was -37.78 ± 0.38 mv, and the particle size of zein nanoparticles stored for 15 days 254.75±12.10nm, PDI was 0.16±0.06, and potential was -31.44±2.31mv. Compared with Example 1, the particle size is significantly reduced, the PDI is reduced, the particle size distribution is narrower, the particle size distribution is uniform, and the potential is increased, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. During the storage process, the particle size of binary zein nanoparticles showed a trend of increasing particle size, PDI increased but not significant, and the potential shifted to a decreasing direction, but the degree of particle size and potential shift were the same. Smaller than unsonicated binary zein nanoparticles, improving the storage stability of the binary nanocomposite.
实施例3Example 3
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为28KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 28KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, and the temperature of the constant temperature water bath to be 25°C, take out the dialysis bag, and re-add 400mL of deionized Water was dialyzed at room temperature for 11 h.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。进行28KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为239.35±2.44nm,PDI为0.14±0.03,电位为-31.13±4.83mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为264.82±2.84nm,PDI为0.15±0.05,电位为-27.77±1.21mv。与实施例1相比较,粒径明显减小,PDI较小,粒径分布较窄,粒度分布均匀,并且电位增加,说明超声促进了均一稳定二元玉米醇溶蛋白纳米颗粒的形成。与实施例2相比较,粒径、PDI数值接近,电位减小。在储藏过程中,28KHz超声处理的二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI增大但是不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm. The particle size of fresh zein nanoparticles subjected to 28KHz sonication was 239.35 ± 2.44 nm, the PDI was 0.14 ± 0.03, the potential was -31.13 ± 4.83 mv, and the particle size of zein nanoparticles stored for 15 days was 264.82±2.84nm, PDI was 0.15±0.05, and the potential was -27.77±1.21mv. Compared with Example 1, the particle size is significantly reduced, the PDI is smaller, the particle size distribution is narrower, the particle size distribution is uniform, and the potential increases, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. Compared with Example 2, the particle size and PDI value are close, and the potential decreases. During the storage process, the particle size of the 28KHz ultrasonic-treated binary zein nanoparticles showed a trend of increasing particle size, PDI increased but not significantly, and the potential shifted to a decreasing direction, but the particle size and potential The degree of transfer is smaller than that of the unsonicated binary zein nanoparticles, which improves the storage stability of the binary nanocomposite.
实施例4Example 4
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为40KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 40KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, the temperature of the constant temperature water bath to be 25°C, take out the dialysis bag, and re-add 400mL of deionized Water was dialyzed at room temperature for 11 h.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。进行40KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为231.20±15.75nm,PDI为0.14±0.01,电位为-32.60±1.32mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为267.93±3.44nm,PDI为0.19±0.03,电位为-26.01±2.08mv。与实施例1相比较,粒径明显减小,PDI较小,粒径分布较窄,粒度分布均匀并且电位增加,说明超声促进了均一稳定二元玉米醇溶蛋白纳米颗粒的形成。与实施例2、3相比,频率增加后得到的纳米颗粒粒径更小。在储藏过程中,40KHz超声处理的二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI增大但是不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm. The particle size of fresh zein nanoparticles subjected to 40KHz sonication was 231.20 ± 15.75 nm, the PDI was 0.14 ± 0.01, the potential was -32.60 ± 1.32 mv, and the particle size of zein nanoparticles stored for 15 days was 267.93±3.44nm, PDI was 0.19±0.03, and the potential was -26.01±2.08mv. Compared with Example 1, the particle size is significantly reduced, the PDI is smaller, the particle size distribution is narrower, the particle size distribution is uniform, and the potential increases, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. Compared with Examples 2 and 3, the nanoparticle size obtained after increasing the frequency is smaller. During the storage process, the particle size of the 40KHz ultrasonic-treated binary zein nanoparticles showed a trend of increasing particle size, PDI increased but not significantly, and the potential shifted to a decreasing direction, but the particle size and potential The degree of transfer is smaller than that of the unsonicated binary zein nanoparticles, which improves the storage stability of the binary nanocomposite.
实施例5Example 5
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为20KHz+28KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 20KHz+28KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, and the temperature of the constant temperature water bath to be 25°C, take out the dialysis bag, and add 400mL of Dialysis was performed against deionized water for 11 h at room temperature.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。进行20KHz+28KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为242.92±1.28nm,PDI为0.13±0.03,电位为-34.84±0.59mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为249.16±2.62nm,PDI为0.11±0.03,电位为-31.65±2.37mv。与实施例1相比较,粒径明显减小,PDI较小,粒径分布较窄,粒度分布均匀,并且电位增加,说明超声促进了均一稳定二元玉米醇溶蛋白纳米颗粒的形成。与实施例1、2、3、4相比,20KHz+28KHz双频处理后得到的纳米颗粒的粒径与电位储藏前后幅度变化小,增强了纳米颗粒的储存稳定性。在储藏过程中,20KHz+28KHz超声处理的二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI变化不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm. The particle size of fresh zein nanoparticles subjected to 20KHz+28KHz ultrasonic treatment was 242.92±1.28nm, the PDI was 0.13±0.03, and the potential was -34.84±0.59mv. The zein nanoparticles stored for 15 days had a The particle size was 249.16±2.62nm, the PDI was 0.11±0.03, and the potential was -31.65±2.37mv. Compared with Example 1, the particle size is significantly reduced, the PDI is smaller, the particle size distribution is narrower, the particle size distribution is uniform, and the potential increases, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. Compared with Examples 1, 2, 3, and 4, the particle size of the nanoparticles obtained after the 20KHz+28KHz dual-frequency treatment and the amplitude before and after potential storage are small, which enhances the storage stability of the nanoparticles. During storage, the particle size of binary zein nanoparticles treated with 20KHz+28KHz ultrasound showed a trend of increasing particle size, PDI did not change significantly, and the potential shifted to a decreasing direction, but the particle size and potential The degree of transfer is smaller than that of the unsonicated binary zein nanoparticles, which improves the storage stability of the binary nanocomposite.
实施例6Example 6
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为28KHz+40KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 28KHz+40KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, and the temperature of the constant temperature water bath to be 25°C, take out the dialysis bag, and add 400mL of Dialysis was performed against deionized water for 11 h at room temperature.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm.
进行28KHz+40KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为236.62±3.26nm,PDI为0.13±0.02,电位为-33.47±1.38mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为242.61±3.15nm,PDI为0.1±0.06,电位为-32.00±1.01mv。与实施例1相比较,粒径明显减小,PDI较小,粒径分布较窄,粒度分布均匀并且电位增加,说明超声促进了均一稳定二元玉米醇溶蛋白纳米颗粒的形成。与实施例2、3、5相比,28KHz+40KHz双频处理后得到的纳米颗粒粒径更小。与实施例2、3、4、5相比,28KHz+40KHz双频处理后得到的纳米颗粒的粒径与电位储藏前后幅度变化小,增强了纳米颗粒的储存稳定性。在储藏过程中,28KHz+40KHz超声处理二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI变化不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。The particle size of fresh zein nanoparticles subjected to 28KHz+40KHz ultrasonic treatment was 236.62±3.26nm, the PDI was 0.13±0.02, the potential was -33.47±1.38mv, and the zein nanoparticles were stored for 15 days. The particle size was 242.61±3.15nm, the PDI was 0.1±0.06, and the potential was -32.00±1.01mv. Compared with Example 1, the particle size is significantly reduced, the PDI is smaller, the particle size distribution is narrower, the particle size distribution is uniform, and the potential increases, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. Compared with Examples 2, 3, and 5, the particle size of nanoparticles obtained after 28KHz+40KHz dual-frequency treatment is smaller. Compared with Examples 2, 3, 4, and 5, the particle size of the nanoparticles obtained after the 28KHz+40KHz dual-frequency treatment and the amplitude before and after potential storage are small, which enhances the storage stability of the nanoparticles. During storage, the particle size of 28KHz+40KHz ultrasonic-treated binary zein nanoparticles showed a trend of increasing particle size, PDI did not change significantly, and the potential shifted to a decreasing direction, but the particle size and potential shifted. The extent of zein nanoparticles is smaller than that of the unsonicated binary zein nanoparticles, which improves the storage stability of the binary nanocomposites.
实施例7Example 7
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为20KHz+40KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 20KHz+40KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, and the temperature of the constant temperature water bath to be 25°C, take out the dialysis bag, and add 400mL of Dialysis was performed against deionized water for 11 h at room temperature.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。进行20KHz+40KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为225.94±45.84nm,PDI为0.17±0.06,电位为-29.97±1.49mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为226.02±11.28nm,PDI为0.19±0.08,电位为-28.50±0.60mv。与实施例1相比较,粒径明显减小,PDI较小,粒径分布较窄,粒度分布均匀,并且电位增加,说明超声促进了均一稳定二元玉米醇溶蛋白纳米颗粒的形成。与实施例2、3、4、5、6相比,双频超声处理优于但单频超声,双频20KHz+40KHz后得到的纳米颗粒粒径更小。与实施例2、3、4、5、6相比,28KHz+40KHz双频处理后得到的纳米颗粒的粒径与电位储藏前后幅度变化小,增强了纳米颗粒的储存稳定性。在储藏过程中,20KHz+40KHz超声处理二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI变化不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm. The particle size of fresh zein nanoparticles subjected to 20KHz+40KHz sonication was 225.94±45.84nm, the PDI was 0.17±0.06, the potential was -29.97±1.49mv, and the zein nanoparticles stored for 15 days were The particle size was 226.02±11.28nm, the PDI was 0.19±0.08, and the potential was -28.50±0.60mv. Compared with Example 1, the particle size is significantly reduced, the PDI is smaller, the particle size distribution is narrower, the particle size distribution is uniform, and the potential increases, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. Compared with Examples 2, 3, 4, 5, and 6, dual-frequency ultrasonic treatment is better than single-frequency ultrasonic treatment, and the nanoparticles obtained after dual-frequency 20KHz+40KHz have smaller particle size. Compared with Examples 2, 3, 4, 5, and 6, the particle size of the nanoparticles obtained after the 28KHz+40KHz dual-frequency treatment and the amplitude before and after potential storage are small, which enhances the storage stability of the nanoparticles. During storage, the particle size of 20KHz+40KHz ultrasonic-treated binary zein nanoparticles showed a trend of increasing particle size, PDI did not change significantly, and the potential shifted to a decreasing direction, but the particle size and potential shifted. The extent of zein nanoparticles is smaller than that of the unsonicated binary zein nanoparticles, which improves the storage stability of the binary nanocomposites.
实施例8Example 8
(1)将一定质量的玉米醇溶蛋白与酪蛋白酸钠溶解在80%(v/v)丙二醇水溶液中,玉米醇溶蛋白与酪蛋白酸钠的质量占比均为2%,储备溶液磁力搅拌均匀目视无明显沉淀,二元混合溶液经5000rpm离心10min去除残留的大颗粒,得到玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液。(1) Dissolve a certain mass of zein and sodium caseinate in an 80% (v/v) propylene glycol aqueous solution, the mass ratio of zein and sodium caseinate is both 2%, and the magnetic Stir well and see no obvious precipitation. The binary mixed solution is centrifuged at 5000 rpm for 10 min to remove the remaining large particles to obtain a binary mixed solution of zein and sodium caseinate.
(2)量取20mL的玉米醇溶蛋白与酪蛋白酸钠的二元混合溶液,装入经过活化处理长度为45cm宽为34mm,截留分子量为8000-14000的透析袋中,将透析袋密封好放入物料容器中,并加入400mL的去离子水。(2) Measure the binary mixed solution of zein and sodium caseinate of 20mL, put into the dialysis bag with a length of 45cm and a width of 34mm after activation treatment, and a molecular weight cut-off of 8000-14000, and seal the dialysis bag. Put into the material container and add 400 mL of deionized water.
(3)把物料容器放置在超声槽中,设置超声频率为20KHz+28KHz+40KHz、超声功率为300w、超声时间60min、超声方式为持续式,恒温水浴温度为25℃,取出透析袋,重新加入400mL的去离子水在室温条件下进行透析11h。(3) Place the material container in the ultrasonic tank, set the ultrasonic frequency to 20KHz+28KHz+40KHz, the ultrasonic power to 300w, the ultrasonic time to 60min, the ultrasonic mode to be continuous, and the temperature of the constant temperature water bath to be 25°C. Take out the dialysis bag and add it again. Dialysis was performed against 400 mL of deionized water for 11 h at room temperature.
(4)透析结束后,取出新鲜样品得到的是玉米醇溶蛋白复合纳米粒子胶体分散液。一部分样品4℃冰箱冷藏,另取一部分胶体溶液进行真空冷冻干燥48h。(4) After the dialysis, take out a fresh sample to obtain a zein composite nanoparticle colloidal dispersion. A part of the samples were refrigerated at 4°C, and another part of the colloidal solution was vacuum freeze-dried for 48h.
(5)浊度测定:取新鲜样品,采用UV-vis紫外可见分光光度计在波长500nm波长下测定样品的吸光度值以表征样品的浊度。在室温条件下测定,每个样品测定三次,结果以平均值表示。(5) Turbidity measurement: Take a fresh sample and measure the absorbance value of the sample at a wavelength of 500 nm using a UV-vis ultraviolet-visible spectrophotometer to characterize the turbidity of the sample. Measured at room temperature, each sample was measured three times, and the results were expressed as an average value.
(6)粒径和Zeta电位的测定:在室温条件下采用动态光散射测定玉米醇溶蛋白二元纳米颗粒的粒度、PDI和Zeta电位。通过仪器基于Stokes-Einstein方程计算每个样品的粒径,而基于Smoluchowski模型计算表面电位,在测量之前将纳米颗粒分散体稀释到合适浓度以避免多重散射效应。所有测量一式三份取平均值。(6) Determination of particle size and Zeta potential: The particle size, PDI and Zeta potential of zein binary nanoparticles were determined by dynamic light scattering at room temperature. The particle size of each sample was calculated by the instrument based on the Stokes-Einstein equation, while the surface potential was calculated based on the Smoluchowski model, and the nanoparticle dispersion was diluted to an appropriate concentration before measurement to avoid multiple scattering effects. All measurements were averaged in triplicate.
(7)荧光光谱测定:为了选择性的激发色氨酸残基,以280nm为激发波长,扫描范围为290-450nm,扫描速度为1000nm/min,扫描间隔:1nm,激发带宽与发射带宽均设定为10nm。(7) Determination of fluorescence spectrum: In order to selectively excite tryptophan residues, the excitation wavelength is 280 nm, the scanning range is 290-450 nm, the scanning speed is 1000 nm/min, the scanning interval is 1 nm, and the excitation bandwidth and emission bandwidth are both set Set to 10nm.
进行20KHz+28KHz+40KHz超声处理的新鲜的玉米醇溶蛋白纳米颗粒的粒径为239.09±3.11nm,PDI为,电位为-34.52±2.62mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为242.48±5.13nm,PDI为,电位为-28.74±5.84mv。与实施例1相比较,粒径明显减小,PDI较小,粒径分布较窄,粒度分布均匀,并且电位增加,说明超声促进了均一稳定的二元玉米醇溶蛋白纳米颗粒的形成。与实施例2、3、5相比,得到的纳米颗粒粒径更小。与实施例2、3、4相比,28KHz+40KHz双频处理后得到的纳米颗粒的粒径与电位储藏前后幅度变化小,增强了纳米颗粒的储存稳定性。在储藏过程中,20KHz+28KHz+40KHz超声处理二元玉米醇溶蛋白纳米颗粒的粒径呈现出粒径增加的趋势,PDI变化不显著,电位则是往减小的方向转移,但是粒径和电位转移的程度均小于未经超声处理的二元玉米醇溶蛋白纳米颗粒,提高了二元纳米复合物的储藏稳定性。The particle size of the fresh zein nanoparticles subjected to 20KHz+28KHz+40KHz ultrasonic treatment is 239.09±3.11nm, the PDI is, the potential is -34.52±2.62mv, and the grain size of the zein nanoparticles stored for 15 days. The diameter is 242.48±5.13nm, the PDI is 242.48±5.13nm, and the potential is -28.74±5.84mv. Compared with Example 1, the particle size is significantly reduced, the PDI is smaller, the particle size distribution is narrower, the particle size distribution is uniform, and the potential increases, indicating that ultrasound promotes the formation of uniform and stable binary zein nanoparticles. Compared with Examples 2, 3, and 5, the obtained nanoparticles have smaller particle size. Compared with Examples 2, 3, and 4, the particle size of the nanoparticles obtained after the 28KHz+40KHz dual-frequency treatment and the amplitude before and after potential storage have small changes, which enhances the storage stability of the nanoparticles. During storage, the particle size of 20KHz+28KHz+40KHz ultrasonic-treated binary zein nanoparticles showed a trend of increasing particle size, PDI did not change significantly, and the potential shifted to a decreasing direction, but the particle size and The degree of potential transfer is smaller than that of the unsonicated binary zein nanoparticles, which improves the storage stability of the binary nanocomposite.
表1是不同储存时间的纳米颗粒粒径、PDI、Zeta电位图。Table 1 is the nanoparticle size, PDI, and Zeta potential maps for different storage times.
经过超声辅助透析处理后的玉米醇溶蛋白纳米颗粒粒径明显减小,PDI值较小,粒径分布较窄,粒度分布均匀,并且电位增加,形成了均一稳定的纳米颗粒。超声与透析双相物理驱动力打开了玉米醇溶蛋白内部高级结构,使更多蛋白质内部的芳香族氨基酸残基暴露,增加了玉米醇溶蛋白胶体溶液的荧光强度。不同组合频率辅助透析处理的纳米颗粒表现出不同的物理特性,其中20KHz+40KHz超声辅助透析处理玉米醇溶蛋白纳米颗粒的粒径为225.94±45.84nm,PDI为0.17±0.06,电位为-29.97±1.49mv,储存了15天的玉米醇溶蛋白纳米颗粒的粒径为226.02±11.28nm,PDI为0.19±0.08,电位为-28.50±0.60mv,粒径最小,荧光强度最强,为最佳优选辅助频率,并且储藏期间粒径电位变化程度小,储藏稳定性好。After ultrasonic-assisted dialysis treatment, the particle size of zein nanoparticles was significantly reduced, the PDI value was smaller, the particle size distribution was narrow, the particle size distribution was uniform, and the potential increased, forming uniform and stable nanoparticles. The biphasic physical driving force of ultrasound and dialysis opened the internal higher-order structure of zein, exposing more aromatic amino acid residues inside the protein, and increasing the fluorescence intensity of the zein colloid solution. The nanoparticles treated with different combined frequencies of assisted dialysis showed different physical properties. The particle size of zein nanoparticles treated by 20KHz+40KHz ultrasonic assisted dialysis was 225.94±45.84nm, the PDI was 0.17±0.06, and the potential was -29.97±29.97± 1.49mv, the particle size of the zein nanoparticles stored for 15 days is 226.02±11.28nm, the PDI is 0.19±0.08, the potential is -28.50±0.60mv, the particle size is the smallest, and the fluorescence intensity is the strongest, which is the best choice Auxiliary frequency, and the degree of particle size potential change during storage is small, and the storage stability is good.
表1不同储存时间的纳米颗粒粒径、PDI、Zeta电位图Table 1 Nanoparticle size, PDI and Zeta potential diagrams of different storage times
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910879019.0A CN110693036A (en) | 2019-09-18 | 2019-09-18 | Ultrasound-assisted dialysis-driven zein self-assembly to prepare nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910879019.0A CN110693036A (en) | 2019-09-18 | 2019-09-18 | Ultrasound-assisted dialysis-driven zein self-assembly to prepare nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693036A true CN110693036A (en) | 2020-01-17 |
Family
ID=69195741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910879019.0A Pending CN110693036A (en) | 2019-09-18 | 2019-09-18 | Ultrasound-assisted dialysis-driven zein self-assembly to prepare nanoparticles |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110693036A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111990643A (en) * | 2020-08-24 | 2020-11-27 | 江苏大学 | A kind of intelligent release protein metal ion antibacterial nanoparticle and preparation method thereof |
CN113383955A (en) * | 2021-06-29 | 2021-09-14 | 江苏大学 | Preparation method and application of zein-gum arabic nanoparticles driven by double-frequency ultrasonic-assisted salt solution dialysis |
CN114052068A (en) * | 2021-12-06 | 2022-02-18 | 陕西科技大学 | Biological membrane with ethylene adsorption performance and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103431156A (en) * | 2013-08-13 | 2013-12-11 | 华南理工大学 | Zein nanoparticle and preparation method thereof |
CN104225607A (en) * | 2014-08-25 | 2014-12-24 | 华南理工大学 | Preparation method of zein microsphere and ultrasonic built-in dialysis device for preparing zein microsphere |
CN106727428A (en) * | 2016-12-23 | 2017-05-31 | 青岛农业大学 | A kind of rutin zeins casein sodium composite nanoparticle and preparation method thereof |
-
2019
- 2019-09-18 CN CN201910879019.0A patent/CN110693036A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103431156A (en) * | 2013-08-13 | 2013-12-11 | 华南理工大学 | Zein nanoparticle and preparation method thereof |
CN104225607A (en) * | 2014-08-25 | 2014-12-24 | 华南理工大学 | Preparation method of zein microsphere and ultrasonic built-in dialysis device for preparing zein microsphere |
CN106727428A (en) * | 2016-12-23 | 2017-05-31 | 青岛农业大学 | A kind of rutin zeins casein sodium composite nanoparticle and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
ASHOK R. PATEL,等: "Sodium Caseinate Stabilized Zein Colloidal Particles", 《农业和食品化学》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111990643A (en) * | 2020-08-24 | 2020-11-27 | 江苏大学 | A kind of intelligent release protein metal ion antibacterial nanoparticle and preparation method thereof |
CN113383955A (en) * | 2021-06-29 | 2021-09-14 | 江苏大学 | Preparation method and application of zein-gum arabic nanoparticles driven by double-frequency ultrasonic-assisted salt solution dialysis |
CN114052068A (en) * | 2021-12-06 | 2022-02-18 | 陕西科技大学 | Biological membrane with ethylene adsorption performance and application thereof |
CN114052068B (en) * | 2021-12-06 | 2024-06-11 | 陕西科技大学 | Biological film with ethylene adsorption performance and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110693036A (en) | Ultrasound-assisted dialysis-driven zein self-assembly to prepare nanoparticles | |
Wang et al. | Structural interplay between curcumin and soy protein to improve the water-solubility and stability of curcumin | |
CN110432377B (en) | Soybean protein isolate chitosan nanogel and preparation method and application thereof | |
Zhang et al. | High internal phase Pickering emulsions stabilized by a cod protein–chitosan nanocomplex for astaxanthin delivery | |
CN108208834B (en) | A kind of soybean protein-based nanoparticle loaded with curcumin and its preparation method and use | |
Chen et al. | Carboxymethylation of phytoglycogen and its interactions with caseinate for the preparation of nanocomplex | |
CN107467662A (en) | A kind of water miscible quercetin nano particle and preparation method thereof | |
CN113230234B (en) | Ultrasonic preparation method of bioactive ingredient-loaded protein peptide-polysaccharide nanoparticles | |
Xu et al. | Soy protein isolate-citrus pectin-gallic acid ternary composite high internal phase Pickering emulsion for delivery of β-carotene: Physicochemical, structural and digestive properties | |
CN108741097A (en) | A kind of albumen self assembly embedding difficult resolving active material nanometer products and preparation method thereof | |
Rao et al. | Physicochemical and antibacterial properties of fabricated ovalbumin–carvacrol gel nanoparticles | |
Shi et al. | Formation mechanism and stability of low environment-sensitive ternary nanoparticles based on zein-pea protein-pectin for astaxanthin delivery | |
Jiao et al. | Improvement in entrapment efficiency and in vitro digestion stability of lutein by zein nanocarriers with pepsin hydrolysis | |
CN108157585A (en) | A kind of soybean protein base nano particle for loading resveratrol and its preparation method and purposes | |
Zhou et al. | A non-thermal modification method to enhance the encapsulation efficiency, stability, and slow-release performance of zein-based delivery systems–Cold plasma | |
CN103648295A (en) | Food-grade encapsulate and process for the production thereof | |
CN115058476A (en) | A kind of preparation method of vegetable protein nanoparticles | |
CN110839873B (en) | Method for preparing polyunsaturated fatty acid microcapsule from chitosan and short amylose | |
CN112121019A (en) | Antioxidative starch-based dextrin composite nanoparticles and preparation method and application thereof | |
Fang et al. | Interaction between soy protein isolate and surfactant at the interface of antibacterial nanoemulsions loaded with riboflavin tetra butyrate | |
CN117337989A (en) | A kind of nanoparticle loaded with curcumin based on pH shift and preparation method thereof | |
CN115381103A (en) | Core-shell type prolamin composite particle and preparation method and application thereof | |
CN113416350B (en) | Preparation method of lactalbumin-epsilon-polylysine-Arabic gum nano-particles | |
CN109770333B (en) | A kind of modified chitosan-modified gliadin hydrolysate nanoparticle and its preparation method and application | |
CN110498932A (en) | Casein-pectin-protocatechuic acid ternary compound, its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |
|
RJ01 | Rejection of invention patent application after publication |